Noile-Immune Biotech (TSE:4893) Inventories, Raw Materials & Components: 円2.15 Mil (As of Dec. 2025)


TSE:4893 Noile-Immune Biotech Inc TSE:4893
53 GF Score
Price 円128.00
GF Value 円4.36
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Noile-Immune Biotech Inventories, Raw Materials & Components?

Noile-Immune Biotech TSE:4893 +4.07% 53 Inventories, Raw Materials & Components is 円2.15 Mil as of Dec. 2025. GuruFocus rates TSE:4893 with a GF Score™ of 53/100 and a GF Value™ of 円4.36 (Significantly Overvalued). The stock has 2 warning signs investors should review.

Noile-Immune Biotech's inventories, raw materials & components for the quarter that ended in Dec. 2025 was 円2.15 Mil.

Noile-Immune Biotech's quarterly raw materials declined from Mar. 2025 (円6.53 Mil) to Jun. 2025 (円5.86 Mil) and declined from Jun. 2025 (円5.86 Mil) to Dec. 2025 (円2.15 Mil).

Noile-Immune Biotech's annual raw materials declined from Dec. 2023 (円20.90 Mil) to Dec. 2024 (円8.57 Mil) and declined from Dec. 2024 (円8.57 Mil) to Dec. 2025 (円2.15 Mil).

Noile-Immune Biotech Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Noile-Immune Biotech's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Noile-Immune Biotech Inventories, Raw Materials & Components Chart

Noile-Immune Biotech Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Raw Materials & Components
Get a 7-Day Free Trial 4.27 3.93 20.90 8.57 2.15

Noile-Immune Biotech Quarterly Data
Dec20 Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Dec25 Mar26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.57 6.53 5.86 2.15 1.74
TSE:4893
53GF Score
Noile-Immune Biotech Inc TSE:4893
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Noile-Immune Biotech Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of 円2.15 Mil mean?
Noile-Immune Biotech (TSE:4893) has a Inventories, Raw Materials & Components of 円2.15 Mil as of Dec. 2025. Raw materials are the components a company uses for its main products. View historical data on Noile-Immune Biotech and its competitors.
Is Noile-Immune Biotech's Inventories, Raw Materials & Components too high?
Noile-Immune Biotech's current Inventories, Raw Materials & Components is 円2.15 Mil. Overall, Noile-Immune Biotech has a GF Score™ of 53/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Noile-Immune Biotech's Inventories, Raw Materials & Components compare to VRTX and REGN?
Noile-Immune Biotech's Inventories, Raw Materials & Components of 円2.15 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Biotechnology company?
A good Inventories, Raw Materials & Components depends on the Biotechnology industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Noile-Immune Biotech and its competitors. Noile-Immune Biotech's current Inventories, Raw Materials & Components is 円2.15 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Noile-Immune Biotech stock overvalued right now?
Based on GuruFocus' analysis, Noile-Immune Biotech (TSE:4893) is currently considered Significantly Overvalued. The stock's GF Value™ is 円4.36, compared to a current price of 円128.00 — trading 2835.8% above its estimated fair value. The current Inventories, Raw Materials & Components is 円2.15 Mil. Noile-Immune Biotech's overall GF Score™ is 53/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Noile-Immune Biotech (TSE:4893), the current Inventories, Raw Materials & Components is 円2.15 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Noile-Immune Biotech (TSE:4893) Overvalued in 2026?

Based on GuruFocus' analysis, Noile-Immune Biotech stock appears to be overvalued. The current stock price of 円128.00 is trading 2835.8% above its estimated GF Value™ of 円4.36. GuruFocus considers Noile-Immune Biotech to be Significantly Overvalued.

Key valuation signals for TSE:4893:

  • Inventories, Raw Materials & Components: 円2.15 Mil
  • GF Value™: 円4.36 vs. price of 円128.00 (2835.8% above fair value)
  • GF Score™: 53/100 with 2 warning signs

No single metric tells the full story. See the TSE:4893 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Noile-Immune Biotech Business Description

Address 2-12-10 Shiba-Daimon, 5th Floor, T&G Hamamatsucho Building, Minato-ku, Yamaguchi, Tokyo, JPN, 105-0012
Noile-Immune Biotech Inc is engaged in the development of CAR-T cell therapy for solid cancers using its proprietary technology. The company's development pipeline and collaborative projects with other companies include different product candidates such as NIB102, NIB103, NIB104, ADAP01, AUTL01, etc. It operates in a single segment, the cancer immunotherapy drug discovery business.
53GF Score

Get the complete analysis for TSE:4893

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円128.00
Price
円4.36
GF Value